Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Daily Top 10 COVID-19 papers

DEU | ENG | ESP | FRA | ITA | POR | TUR | VNM


  Diabetes

  Free Subscription


Articles published in Am J Ophthalmol

Retrieve available abstracts of 68 articles:
HTML format



Single Articles


    May 2020
  1. MULLER PL, Tufail A
    Progression of Retinopathy Secondary to Maternally Inherited Diabetes and Deafness - Evaluation of Predicting Parameters.
    Am J Ophthalmol. 2020 May 8. pii: S0002-9394(20)30103.
    PubMed    


    April 2020
  2. YOU QS, Wang J, Guo Y, Pi S, et al
    Optical coherence tomography angiography avascular area association with one-year treatment requirement and disease progression in diabetic retinopathy.
    Am J Ophthalmol. 2020 Apr 29. pii: S0002-9394(20)30192.
    PubMed     Abstract available


  3. FINSTERER J, Scorza FA, Scorza CA
    Comment on Progression of Retinopathy Secondary to Maternally Inherited Diabetes and Deafness: Evaluation of Predicting Parameters.
    Am J Ophthalmol. 2020 Apr 28. pii: S0002-9394(20)30100.
    PubMed    


  4. GOVETTO A, Sarraf D, Hubschman JP, Tadayoni R, et al
    Distinctive Mechanisms and Patterns of Exudative Versus Tractional Intraretinal Cystoid Spaces as Seen With Multimodal Imaging.
    Am J Ophthalmol. 2020;212:43-56.
    PubMed     Abstract available


    March 2020
  5. GREEN M, Tien T, Ness S
    Predictors of Loss to Follow Up in Patients Being Treated for Proliferative Diabetic Retinopathy.
    Am J Ophthalmol. 2020 Mar 31. pii: S0002-9394(20)30123.
    PubMed     Abstract available


  6. ITO H, Ito Y, Kataoka K, Ueno S, et al
    Association between retinal layer thickness and perfusion status in extramacular areas in diabetic retinopathy.
    Am J Ophthalmol. 2020 Mar 26. pii: S0002-9394(20)30119.
    PubMed     Abstract available


  7. SURESH R, Yu H, Thoveson A, Swisher J, et al
    Loss to Follow-Up Among Patients with Proliferative Diabetic Retinopathy in Clinical Practice.
    Am J Ophthalmol. 2020 Mar 21. pii: S0002-9394(20)30111.
    PubMed     Abstract available


  8. CICINELLI MV, Rabiolo A, Zollet P, Capone L, et al
    Persistent or Recurrent Diabetic Macular Edema after Fluocinolone Acetonide 0.19 mg Implant: risk factors and management.
    Am J Ophthalmol. 2020 Mar 21. pii: S0002-9394(20)30116.
    PubMed     Abstract available


  9. ZHU Y, Cui Y, Wang JC, Lu Y, et al
    Different Scan Protocols Affect the Detection Rates of Diabetic Retinopathy Lesions by Wide-field Swept-Source Optical Coherence Tomography Angiography.
    Am J Ophthalmol. 2020 Mar 20. pii: S0002-9394(20)30102.
    PubMed     Abstract available


    February 2020
  10. QIN YJ, Chan SO, Lin HL, Zhang YQ, et al
    Increased expression of growth hormone-releasing hormone in fibrinous inflammation of proliferative diabetic retinopathy.
    Am J Ophthalmol. 2020 Feb 13. pii: S0002-9394(20)30059.
    PubMed     Abstract available


  11. HAINSWORTH DP, Gangula A, Ghoshdastidar S, Kannan R, et al
    Diabetic Retinopathy Screening Using a Gold Nanoparticle-Based Paper Strip Assay for the At-Home Detection of the Urinary Biomarker 8-Hydroxy-2'-deoxyguanosine (8-OHdG).
    Am J Ophthalmol. 2020 Feb 6. pii: S0002-9394(20)30050.
    PubMed     Abstract available


    January 2020
  12. RUSSELL JF, Al-Khersan H, Shi Y, Scott NL, et al
    Retinal Non-Perfusion in Proliferative Diabetic Retinopathy Before and After Panretinal Photocoagulation Assessed by Wide Field OCT Angiography.
    Am J Ophthalmol. 2020 Jan 29. pii: S0002-9394(20)30033.
    PubMed     Abstract available


  13. MULLER PL, Treis T, Pfau M, Esposti SD, et al
    Progression of Retinopathy Secondary to Maternally Inherited Diabetes and Deafness - Evaluation of Predicting Parameters.
    Am J Ophthalmol. 2020 Jan 24. pii: S0002-9394(20)30019.
    PubMed     Abstract available


  14. SANDHU HS, Elmogy M, El-Adawy N, Eltanboly A, et al
    Automated diagnosis of diabetic retinopathy using clinical biomarkers, optical coherence tomography (OCT), and OCT angiography.
    Am J Ophthalmol. 2020 Jan 23. pii: S0002-9394(20)30023.
    PubMed     Abstract available


    November 2019
  15. SRINIVAS S, Verma A, Nittala MG, Alagorie AR, et al
    Effect of intravitreal ranibizumab on intraretinal hard exudates in eyes with diabetic macular edema.
    Am J Ophthalmol. 2019 Nov 20. pii: S0002-9394(19)30562.
    PubMed     Abstract available


    September 2019
  16. HAFNER J, Zadrazil M, Grisold A, Ricken G, et al
    Retinal and corneal neurodegeneration and its association to systemic signs of peripheral neuropathy in type 2 diabetes.
    Am J Ophthalmol. 2019 Sep 19. pii: S0002-9394(19)30468.
    PubMed     Abstract available


    August 2019
  17. FAN W, Nittala MG, Fleming A, Robertson G, et al
    Relationship Between Retinal Fractal Dimension and Non-perfusion in Diabetic Retinopathy on Ultra-Wide Field Fluorescein Angiography.
    Am J Ophthalmol. 2019 Aug 28. pii: S0002-9394(19)30416.
    PubMed     Abstract available


    June 2019
  18. YORGUN MA
    Effects of Crocin on Diabetic Maculopathy: A Placebo-Controlled Randomized Clinical Trial.
    Am J Ophthalmol. 2019 Jun 27. pii: S0002-9394(19)30129.
    PubMed    


  19. SEPAHI S, Mohajeri SA, Hosseini SM, Khodaverdi E, et al
    Effects of Crocin on Diabetic Maculopathy: A Placebo-Controlled Randomized Clinical Trial.
    Am J Ophthalmol. 2019 Jun 20. pii: S0002-9394(19)30128.
    PubMed    


  20. VAIL D, Callaway NF, Ludwig CA, Saroj N, et al
    Lipid-Lowering Medications are Associated with Lower Risk of Retinopathy and Ophthalmic Interventions among U.S. Patients with Diabetes.
    Am J Ophthalmol. 2019 Jun 10. pii: S0002-9394(19)30264.
    PubMed     Abstract available


  21. RUSSELL JF, Flynn HW Jr, Sridhar J, Townsend JH, et al
    Distribution of Diabetic Neovascularization on Ultra-Widefield Fluorescein Angiography and on Simulated Widefield OCT Angiography.
    Am J Ophthalmol. 2019 Jun 10. pii: S0002-9394(19)30266.
    PubMed     Abstract available


    May 2019
  22. LAVILLE V, Kang JH, Cousins CC, Iglesias AI, et al
    Genetic correlations between diabetes and glaucoma: an analysis of continuous and dichotomous phenotypes.
    Am J Ophthalmol. 2019 May 20. pii: S0002-9394(19)30245.
    PubMed     Abstract available


  23. MAN RE, Gan AT, Gupta P, Fenwick EK, et al
    Is Myopia associated with the Incidence and Progression of Diabetic Retinopathy?
    Am J Ophthalmol. 2019 May 16. pii: S0002-9394(19)30232.
    PubMed     Abstract available


  24. AREVALO JF, Lasave AF, Kozak I, Al Rashaed S, et al
    Preoperative Intravitreal Bevacizumab for Tractional Retinal Detachment Secondary to Proliferative Diabetic Retinopathy: Prospective Randomized Clinical Trial of the Pan-American Collaborative Retina Study (PACORES) Group.
    Am J Ophthalmol. 2019 May 13. pii: S0002-9394(19)30227.
    PubMed     Abstract available


  25. FAWZI AA, Fayed AE, Linsenmeier RA, Gao J, et al
    IMPROVED MACULAR CAPILLARY FLOW ON OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY AFTER PANRETINAL PHOTOCOAGULATION FOR PROLIFERATIVE DIABETIC RETINOPATHY.
    Am J Ophthalmol. 2019 May 9. pii: S0002-9394(19)30214.
    PubMed     Abstract available


  26. FAN W, Nittala MG, Velaga SB, Hirano T, et al
    Distribution of Non-perfusion and Neovascularization on Ultra-Wide Field Fluorescein Angiography in Proliferative Diabetic Retinopathy (RECOVERY Study): Report 1.
    Am J Ophthalmol. 2019 May 9. pii: S0002-9394(19)30204.
    PubMed     Abstract available


  27. SPAIDE RF
    Measurable Aspects Of The Retinal Neurovascular Unit In Diabetes, Glaucoma And Controls.
    Am J Ophthalmol. 2019 May 9. pii: S0002-9394(19)30217.
    PubMed     Abstract available


    April 2019
  28. INANC M, Tekin K, Kiziltoprak H, Ozalkak S, et al
    Changes in Retinal Microcirculation Precede the Clinical Onset of Diabetic Retinopathy in Children with Type 1 Diabetes Mellitus.
    Am J Ophthalmol. 2019 Apr 19. pii: S0002-9394(19)30186.
    PubMed     Abstract available


  29. FELFELI T, Juncal VR, Hillier RJ, Mak MY, et al
    Aqueous Humor Cytokines and Long-Term Response to Anti-Vascular Endothelial Growth Factor Therapy in Diabetic Macular Edema.
    Am J Ophthalmol. 2019 Apr 5. pii: S0002-9394(19)30151.
    PubMed     Abstract available


  30. FANG M, Fan W, Shi Y, Ip MS, et al
    Classification of Regions of Nonperfusion on Ultra-widefield Fluorescein Angiography in patients with Diabetic Macular Edema.
    Am J Ophthalmol. 2019 Apr 5. pii: S0002-9394(19)30141.
    PubMed     Abstract available


  31. GRZYBOWSKI A, Adamiec-Mroczek J
    Diabetes Alone Does Not Impair Recovery From Uneventful Cataract Surgery.
    Am J Ophthalmol. 2019;200:224-225.
    PubMed    


    March 2019
  32. WUBBEN TJ, Johnson MW
    Anti-VEGF Therapy for Diabetic Retinopathy: Consequences of Inadvertent Treatment Interruptions.
    Am J Ophthalmol. 2019 Mar 13. pii: S0002-9394(19)30103.
    PubMed     Abstract available


    February 2019
  33. TAIPALE C, Ilveskoski L, Danni R, Tuuminen R, et al
    Diabetes Alone Does Not Impair Recovery From Uneventful Cataract Surgery.
    Am J Ophthalmol. 2019 Feb 8. pii: S0002-9394(19)30017.
    PubMed    


  34. PAVKOV ME, Harding JL, Chou CF, Saaddine JB, et al
    Prevalence of Diabetic Retinopathy and Associated Mortality Among Diabetic Adults With and Without Chronic Kidney Disease.
    Am J Ophthalmol. 2019;198:200-208.
    PubMed     Abstract available


    January 2019
  35. ROSEN RB, Andrade Romo JS, Krawitz BD, Mo S, et al
    Earliest Evidence of Preclinical Diabetic Retinopathy Revealed using OCT Angiography (OCTA) Perfused Capillary Density.
    Am J Ophthalmol. 2019 Jan 25. pii: S0002-9394(19)30025.
    PubMed     Abstract available


    December 2018
  36. MAGGIO E, Sartore M, Attanasio M, Maraone G, et al
    Reply to: Anti-Vascular Endothelial Growth Factor Treatment for Diabetic Macular Edema in a Real-World Clinical Setting.
    Am J Ophthalmol. 2018 Dec 21. pii: S0002-9394(18)30597.
    PubMed    


  37. GANDHI JS
    Anti-Vascular Endothelial Growth Factor Treatment for Diabetic Macular Edema in a Real-World Clinical Setting.
    Am J Ophthalmol. 2018 Dec 20. pii: S0002-9394(18)30596.
    PubMed    


  38. LUTSKI M, Shohat T, Mery N, Zucker I, et al
    Incidence and risk factors for blindness in adults with diabetes: the Israeli National Diabetes Registry (INDR).
    Am J Ophthalmol. 2018 Dec 19. pii: S0002-9394(18)30679.
    PubMed     Abstract available


  39. HAGENAU F, Vogt D, Ziada J, Guenther SR, et al
    Vitrectomy for diabetic macular edema: optical coherence tomography criteria and pathology of the vitreomacular interface.
    Am J Ophthalmol. 2018 Dec 14. pii: S0002-9394(18)30673.
    PubMed     Abstract available


  40. LIU R, Ma B, Gao Y, Ma B, et al
    Tear Inflammatory Cytokines Analysis and Clinical Correlations in Diabetes and Non-diabetes with Dry Eye.
    Am J Ophthalmol. 2018 Dec 12. pii: S0002-9394(18)30669.
    PubMed     Abstract available


    October 2018
  41. DANNI R, Taipale C, Ilveskoski L, Tuuminen R, et al
    Diabetes alone does not impair recovery from uneventful cataract surgery.
    Am J Ophthalmol. 2018 Oct 8. pii: S0002-9394(18)30572.
    PubMed     Abstract available


  42. PARRAVANO M, De Geronimo D, Scarinci F, Virgili G, et al
    Progression of diabetic microaneurysms according to the internal reflectivity on structural OCT and visibility on OCT angiography.
    Am J Ophthalmol. 2018 Oct 8. pii: S0002-9394(18)30573.
    PubMed     Abstract available


  43. PAN J, Chen D, Yang X, Zou R, et al
    Characteristics of Neovascularization in Early Stages of Proliferative Diabetic Retinopathy by Optical Coherence Tomography Angiography.
    Am J Ophthalmol. 2018 Oct 6. pii: S0002-9394(18)30504.
    PubMed    


  44. CHOWDHARY N, Shrivastav A, Koundanya VV, Mayor R, et al
    Characteristics of Neovascularization in Early Stages of Proliferative Diabetic Retinopathy by Optical Coherence Tomography Angiography.
    Am J Ophthalmol. 2018 Oct 5. pii: S0002-9394(18)30503.
    PubMed    


    September 2018
  45. MAGGIO E, Sartore M, Attanasio M, Maraone G, et al
    Anti-VEGF Treatment for Diabetic Macular Edema in a Real-World Clinical Setting.
    Am J Ophthalmol. 2018 Sep 29. pii: S0002-9394(18)30490.
    PubMed    


  46. CALUGARU D, Calugaru M
    Anti-VEGF Treatment for Diabetic Macular Edema in a Real-World Clinical Setting.
    Am J Ophthalmol. 2018 Sep 27. pii: S0002-9394(18)30489.
    PubMed    


  47. KIM K, Kim ES, Yu SY
    Longitudinal relationship between retinal diabetic neurodegeneration and progression of diabetic retinopathy in patients with type 2 diabetes.
    Am J Ophthalmol. 2018 Sep 6. pii: S0002-9394(18)30515.
    PubMed     Abstract available


    August 2018
  48. PAN J, Chen D, Yang X, Zou R, et al
    Characteristics of Neovascularization in Early Stages of Proliferative Diabetic Retinopathy by Optical Coherence Tomography Angiography.
    Am J Ophthalmol. 2018 Aug 27. pii: S0002-9394(18)30411.
    PubMed    


  49. OLI A, Balakrishnan D
    Characteristics of Neovascularization in Early Stages of Proliferative Diabetic Retinopathy by Optical Coherence Tomography Angiography.
    Am J Ophthalmol. 2018 Aug 25. pii: S0002-9394(18)30410.
    PubMed    


  50. MORA N, Kempen JH, Sobrin L
    Diabetic Retinopathy in Hispanics: A Perspective on Disease Burden.
    Am J Ophthalmol. 2018 Aug 20. pii: S0002-9394(18)30473.
    PubMed     Abstract available


  51. MAGGIO E, Sartore M, Attanasio M, Maraone G, et al
    Anti-VEGF Treatment for Diabetic Macular Edema in a Real-World Clinical Setting.
    Am J Ophthalmol. 2018 Aug 8. pii: S0002-9394(18)30444.
    PubMed     Abstract available


  52. BRESSLER NM, Beaulieu WT, Maguire MG, Glassman AR, et al
    Early Response to Anti-Vascular Endothelial Growth Factor and Two-Year Outcomes Among Eyes with Diabetic Macular Edema in Protocol T.
    Am J Ophthalmol. 2018 Aug 2. pii: S0002-9394(18)30413.
    PubMed     Abstract available


    July 2018
  53. CHEN T, Zhu W, Tang B, Jin L, et al
    A Mobile Phone Informational Reminder to Improve Eyecare Adherence among Diabetic Patient in Rural China: A Randomized Controlled Trial.
    Am J Ophthalmol. 2018 Jul 24. pii: S0002-9394(18)30387.
    PubMed     Abstract available


    June 2018
  54. CALUGARU D, Calugaru M
    Vision Outcomes Following Anti-Vascular Endothelial Growth Factor Treatment of Diabetic Macular Edema in Clinical Practice.
    Am J Ophthalmol. 2018 Jun 30. pii: S0002-9394(18)30293.
    PubMed    


    May 2018
  55. PAN J, Chen D, Yang X, Zou R, et al
    Characteristics of Neovascularization in Early Stages of Proliferative Diabetic Retinopathy by Optical Coherence Tomography Angiography.
    Am J Ophthalmol. 2018 May 25. pii: S0002-9394(18)30236.
    PubMed     Abstract available


    April 2018
  56. HOLEKAMP NM, Campbell J, Almony A, Ingraham H, et al
    Vision Outcomes Following Anti-Vascular Endothelial Growth Factor Treatment of Diabetic Macular Edema in Clinical Practice.
    Am J Ophthalmol. 2018 Apr 20. pii: S0002-9394(18)30170.
    PubMed     Abstract available


  57. YU CG, Yuan SS, Yang LY, Ke J, et al
    Angiopoietin-like 3 is a Potential Biomarker for Retinopathy in Type 2 Diabetic Patients.
    Am J Ophthalmol. 2018 Apr 2. pii: S0002-9394(18)30155.
    PubMed     Abstract available


    March 2018
  58. SEPAHI S, Mohajeri SA, Hosseini SM, Khodaverdi E, et al
    Effects of crocin on diabetic maculopathy; a placebo controlled randomized clinical trial.
    Am J Ophthalmol. 2018 Mar 14. pii: S0002-9394(18)30105.
    PubMed     Abstract available


    February 2018
  59. HOU H, Shoji T, Zangwill LM, Moghimi S, et al
    Progression of Primary Open Angle Glaucoma in Diabetic and Non-diabetic Patients.
    Am J Ophthalmol. 2018 Feb 12. pii: S0002-9394(18)30051.
    PubMed     Abstract available


    January 2018
  60. CASTILLO J, Aleman I, Rush SW, Rush RB, et al
    Preoperative Bevacizumab Administration in Proliferative Diabetic Retinopathy Patients Undergoing Vitrectomy: A Randomized and Controlled Trial Comparing Interval Variation.
    Am J Ophthalmol. 2018 Jan 12. pii: S0002-9394(17)30537.
    PubMed    


  61. OLI A, Balakrishnan D, Rani PK
    Preoperative Bevacizumab Administration in Proliferative Diabetic Retinopathy Patients Undergoing Vitrectomy: A Randomized and Controlled Trial Comparing Interval Variation.
    Am J Ophthalmol. 2018 Jan 12. pii: S0002-9394(17)30538.
    PubMed    


  62. ZHANG XZ, Tu WJ, Wang H, Zhao Q, et al
    Circulating serum fatty acid binding protein 4 levels predict the development of the diabetic retinopathy in type 2 diabetic patients.
    Am J Ophthalmol. 2018 Jan 2. pii: S0002-9394(17)30560.
    PubMed     Abstract available


    December 2017
  63. GOWER EW, Lovato JF, Ambrosius WT, Chew EY, et al
    Lack of Longitudinal Association between Thiazolidinediones and Incidence and Progression of Diabetic Eye Disease: The ACCORD EYE Study.
    Am J Ophthalmol. 2017 Dec 21. pii: S0002-9394(17)30536.
    PubMed     Abstract available


  64. AL-KHERSAN H, Hariprasad SM, Chhablani J
    Early Response to Intravitreal Dexamethasone Implant Therapy in Diabetic Macular Edema May Predict Visual Outcome.
    Am J Ophthalmol. 2017 Dec 9. pii: S0002-9394(17)30470.
    PubMed    


  65. CALUGARU D, Calugaru M
    Early Response to Intravitreal Dexamethasone Implant Therapy in Diabetic Macular Edema May Predict Visual Outcome.
    Am J Ophthalmol. 2017 Dec 5. pii: S0002-9394(17)30474.
    PubMed    


    October 2017
  66. AL-KHERSAN H, Hariprasad SM, Chhablani J
    Early response to intravitreal dexamethasone implant therapy in diabetic macular edema may predict visual outcome.
    Am J Ophthalmol. 2017 Oct 12. pii: S0002-9394(17)30427.
    PubMed     Abstract available


  67. WANG JC, Lains I, Providencia J, Armstrong GW, et al
    Diabetic Choroidopathy: Choroidal Vascular Density and Volume in Diabetic Retinopathy with Swept-Source Optical Coherence Tomography.
    Am J Ophthalmol. 2017 Oct 5. pii: S0002-9394(17)30422.
    PubMed     Abstract available


  68. JOHNSON CA, Thapa S, George Kong YX, Robin AL, et al
    Performance of an iPad Application to Detect Moderate and Advanced Visual Field Loss in Nepal.
    Am J Ophthalmol. 2017;182:147-154.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Diabetes is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: